Induction chemotherapy in AML leads to a shift in p53 protein isoform expression, with increased p53 full length (FL) and decreased p53β/γ protein isoforms, accompanied by elevated expression of p53 target genes [19]. Here, TP53 is linked to acute myeloid leukemia.